Louis Pinkham V - 15 May 2025 Form 4 Insider Report for REGAL REXNORD CORP (RRX)

Role
Chief Executive Officer, Director
Signature
/s/ Hugo Dubovoy Jr., as Power of Attorney
Issuer symbol
RRX
Transactions as of
15 May 2025
Net transactions value
-$2,634,556
Form type
4
Filing time
16 May 2025, 16:46:20 UTC
Previous filing
16 Apr 2025
Next filing
16 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pinkham Louis V. Chief Executive Officer, Director 111 WEST MICHIGAN STREET, MILWAUKEE /s/ Hugo Dubovoy Jr., as Power of Attorney 16 May 2025 0001560596

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RRX Common Stock Options Exercise $4,009,453 +47,511 +34% $84.39 186,547 15 May 2025 Direct F1
transaction RRX Common Stock Sale $1,102,215 -7,866 -4.2% $140.12 178,681 15 May 2025 Direct F1, F2
transaction RRX Common Stock Sale $384,349 -2,727 -1.5% $140.94 175,954 15 May 2025 Direct F1, F3
transaction RRX Common Stock Tax liability $5,157,445 -36,918 -21% $139.70 139,036 15 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RRX Stock Appreciation Rights Options Exercise $0 -47,511 -100% $0.000000 0 15 May 2025 Common Stock 47,511 $84.39 Direct F4
holding RRX Stock Appreciation Rights 33,374 15 May 2025 Common Stock 33,374 $133.77 Direct F4
holding RRX Stock Appreciation Rights 32,723 15 May 2025 Common Stock 32,723 $151.27 Direct F4
holding RRX Stock Appreciation Rights 30,327 15 May 2025 Common Stock 30,327 $154.20 Direct F4
holding RRX Stock Appreciation Rights 28,560 15 May 2025 Common Stock 28,560 $168.47 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of Stock Appreciation Rights ("SARs") expiring on February 18, 2030. All of the 10,593 underlying shares that the reporting person received net of shares withheld to cover the SARs' exercise price and applicable taxes were sold as indicated in this Form 4 for tax and estate planning purposes.
F2 The price in Column 4 is a weighted average price. The prices actually received ranged from $139.750 to $140.480. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
F3 The price in Column 4 is a weighted average price. The prices actually received ranged from $140.825 to $141.025. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
F4 The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.